V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010695 | 280011783 | 1.78 | 108.6 | Palliative (P) | 2017-02-25 | 2017-03-04 | Dacarbazine | N | N | 280030339 | AZACITIDINE |
| 280010696 | 280010771 | 1.85 | 68.4 | Palliative (P) | 2017-12-06 | 2017-12-07 | CISPLATIN + ETOPOSIDE | N | null | 280030350 | DACARBAZINE |
| 280010697 | 280006472 | null | 82.7 | Palliative (P) | 2018-05-28 | 2018-05-28 | Cisplatin + Doxorubicin | 2 | N | 280030355 | CISPLATIN + FLUOROURACIL + RT |
| 280010698 | 280009375 | 1.7 | 36.7 | Palliative (P) | 2015-07-18 | 2017-05-22 | Cisplatin + Pemetrexed | 2 | N | 280030360 | CYCLOPHOSPHAMIDE + DOXORUBICIN |
| 280010699 | 280006476 | 1.56 | null | Adjuvant (A) | 2018-08-15 | 2018-08-19 | Cisplatin + Fluorouracil + RT 5day | N | N | 280030371 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280010700 | 280006478 | 1.66 | 74.2 | Curative (C) | 2018-07-27 | 2018-08-03 | IPM | N | N | 280030373 | CARBO + FLUOROURACIL |
| 280010701 | 280006483 | 1.63 | 74.2 | null | 2015-03-19 | 2015-04-21 | BUSULFAN + MELPHALAN | N | N | 280030383 | IVADO |
| 280010702 | 280006485 | 1.8 | null | Palliative (P) | 2018-01-12 | 2018-02-04 | Cyclophosphamide + Vincristine | 02 | N | 280030387 | NIVOLUMAB |
| 280010703 | 280006489 | null | 87 | Palliative (P) | null | 2019-08-17 | EURAMOS TRIAL | 2 | N | 280030403 | CISPLATIN + FLUOROURACIL + RT |
| 280010704 | 280010776 | 1.65 | null | Palliative (P) | null | 2018-07-18 | STREPTOZOCIN | 02 | N | 280030412 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010705 | 280009384 | 1.8 | 41.2 | Palliative (P) | 2015-08-22 | 2015-09-14 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280030421 | CARBO + FLUOROURACIL |
| 280010706 | 280006494 | 1.85 | 56.7 | Palliative (P) | 2013-06-18 | 2013-07-08 | Cisplatin + Doxorubicin | N | N | 280030432 | CARBO + FLUOROURACIL |
| 280010707 | 280006495 | 1.63 | 74.2 | Palliative (P) | 2016-02-19 | 2016-03-08 | DARS Trial | N | N | 280030436 | CARBOPLATIN + CETUXIMAB |
| 280010708 | 280009387 | 1.59 | 71.2 | Palliative (P) | 2017-12-30 | 2018-01-07 | Fluouracil continuous infusion | N | N | 280030448 | CETUXIMAB + MDG |
| 280010709 | 280006498 | 1.72 | 63 | Palliative (P) | 2017-02-17 | 2017-03-14 | GemCarbo Days 1+8 | N | N | 280030450 | CARBO + FLUOROURACIL |
| 280010710 | 280006502 | 1.73 | 56.7 | Palliative (P) | 2016-07-10 | 2016-08-17 | LANREOTIDE | 02 | N | 280030464 | LIPOSOMAL DOXORUBICIN |
| 280010711 | 280010777 | 1.84 | null | null | 2018-05-10 | 2018-05-10 | IDELALISIB | null | N | 280030466 | GEMCARBO |
| 280010712 | 280006505 | 1.9 | 62 | null | 2016-01-13 | 2016-01-23 | Panitumumab | N | N | 280030468 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010713 | 280006508 | 1.74 | 86.3 | null | 2013-06-18 | 2013-06-18 | LANREOTIDE | null | null | 280030483 | CISPLATIN + FLUOROURACIL + RT |
| 280010714 | 280011951 | 1.7 | 153 | Palliative (P) | 2017-10-16 | 2017-12-07 | Fluorouricil + Folonic Acid (MdG) | N | N | 280030489 | PEMETREXED |
| 280010715 | 280006513 | 1.66 | 76.3 | Curative (C) | 2015-10-13 | 2016-09-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 280030508 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280010716 | 280006514 | 1.67 | 73 | Palliative (P) | 2017-06-29 | 2017-06-29 | ETOPOSIDE | 2 | N | 280030509 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010717 | 280006518 | 0.92 | 85.3 | null | 2013-04-04 | 2013-05-29 | Cyclophosphamide High Dose | Y | N | 280030511 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280010718 | 280006518 | 1.76 | 82 | Palliative (P) | 2018-05-23 | 2018-07-04 | ECarboX | N | N | 280030511 | CISPLATIN + FLUOROURACIL + RT |
| 280010719 | 280009396 | 1.85 | null | Palliative (P) | 2014-09-27 | 2014-10-05 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 280030517 | VIDE |
| 280010720 | 280009397 | null | 86.3 | null | 2014-11-07 | 2014-12-01 | CAPECITABINE + IRINOTECAN | 1 | N | 280030524 | NIVOLUMAB |
| 280010721 | 280006523 | null | 90 | Disease modification (D) | 2016-04-15 | 2016-04-16 | CARBOPLATIN + VINORELBINE | 02 | N | 280030527 | IPILIMUMAB |
| 280010722 | 280006524 | 1.74 | 81.2 | Palliative (P) | null | 2017-05-15 | Docetaxel + Nintedanib | null | null | 280030530 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280010723 | 280011460 | 1.72 | 61.8 | Palliative (P) | null | 2018-06-01 | Avelumab | 02 | N | 280030533 | VIDE |
| 280010724 | 280006526 | 1.6 | null | Palliative (P) | 2015-07-19 | 2015-07-19 | Carboplatin + Topotecan | N | N | 280030542 | CISPLATIN + VINORELBINE |
| 280010725 | 280006530 | 1.76 | 80.8 | Palliative (P) | 2017-06-15 | 2017-07-28 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 2 | N | 280030568 | CARBO + FLUOROURACIL |
| 280010726 | 280012129 | 1.61 | 6.2 | Palliative (P) | 2016-11-12 | 2016-11-27 | STS Rhabdo rel BERNIE Vinor Cyclo | null | null | 280030583 | VIDE |
| 280010727 | 280006531 | 1.67 | null | Palliative (P) | 2017-03-25 | 2017-03-25 | LANREOTIDE | 02 | N | 280030588 | DARS TRIAL |
| 280010728 | 280009404 | 1.9 | 94 | Palliative (P) | 2016-01-10 | 2016-01-28 | VIDE | N | N | 280030591 | CARBOPLATIN + CETUXIMAB + FU |
| 280010729 | 280006534 | 1.6 | 66.3 | Palliative (P) | null | 2014-12-30 | DACTINOMYCIN + CYCLO + VINCRISTINE | 02 | N | 280030598 | RITUXIMAB |
| 280010730 | 280009406 | 1.68 | null | Palliative (P) | 2019-03-21 | 2019-03-21 | IFOSFAMIDE + VINCRISTINE | 02 | N | 280030627 | DACARBAZINE |
| 280010731 | 280006537 | 1.69 | null | Disease modification (D) | 2016-09-13 | 2016-09-13 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 02 | N | 280030628 | IFOSFAMIDE + VINCRISTINE |
| 280010732 | 280006539 | 1.81 | null | Palliative (P) | 2016-08-05 | 2016-08-28 | CARBOPLATIN + FLUOROURACIL | null | null | 280030629 | VIDE |
| 280010733 | 280006543 | 1.8 | 15.4 | Palliative (P) | 2014-06-21 | 2014-09-21 | IVADo | N | N | 280030635 | DACARBAZINE |
| 280010734 | 280006545 | 1.58 | 81 | Palliative (P) | 2018-10-17 | 2018-10-25 | DARS Trial | 2 | N | 280030636 | CISPLATIN + FLUOROURACIL + RT |
| 280010735 | 280006547 | 1.73 | null | Palliative (P) | 2015-09-12 | 2015-10-01 | IPILIMUMAB + NIVOLUMAB | 02 | Y | 280030639 | VIDE |
| 280010736 | 280011464 | 1.65 | 80.5 | Palliative (P) | null | 2018-05-16 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 02 | N | 280030646 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280010737 | 280006551 | 1.8 | 77 | Curative (C) | 2016-05-27 | 2016-06-11 | VIDE | Y | N | 280030660 | IVADO |
| 280010738 | 280009412 | 1.73 | 89.8 | null | 2017-03-16 | 2017-04-16 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 280030663 | BUSULFAN + MELPHALAN |
| 280010739 | 280006554 | 1.52 | 82.8 | Palliative (P) | 2014-12-02 | 2014-12-29 | VINCRISTINE | Y | Y | 280030674 | ABVD |
| 280010740 | 280006555 | 1.65 | 64 | Palliative (P) | 2016-08-06 | 2016-09-17 | KESTREL Trial | N | N | 280030686 | METHOTREXATE |
| 280010741 | 280006562 | 1.46 | 80.5 | Disease modification (D) | 2013-12-12 | 2013-12-19 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 280030695 | CISPLATIN + DOXORUBICIN |
| 280010742 | 280006564 | 1.69 | 141 | Curative (C) | 2018-11-29 | 2018-12-20 | TRASTUZUMAB | N | N | 280030699 | TEMOZOLOMIDE |
| 280010743 | 280006568 | 1.69 | 79 | Palliative (P) | 2018-07-28 | 2018-08-27 | EOX | null | null | 280030702 | DACARBAZINE |
| 280010744 | 280009417 | 1.68 | 77.7 | Adjuvant (A) | 2017-12-05 | 2017-12-05 | Pazopanib | N | N | 280030705 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |